clone
express
character
fulllength
variou
solubl
fragment
sarscov
isol
glycoprotein
cell
express
fuse
receptorexpress
cell
neutral
ph
suggest
recombin
glycoprotein
function
membran
fusogen
activ
requir
viral
protein
low
ph
requir
trigger
membran
fusion
fusion
observ
low
receptor
concentr
solubl
ectodomain
e
cleav
signific
degre
ran
kda
sd
gel
suggest
posttransl
modif
predict
previou
comput
analysi
observ
coronavirus
fragment
contain
ntermin
amino
acid
residu
bound
specif
vero
cell
purifi
solubl
receptor
recent
identifi
farzan
cowork
natur
togeth
data
inhibit
bind
antibodi
develop
peptid
find
suggest
receptorbind
domain
locat
amino
acid
residu
result
also
confirm
function
receptor
sar
viru
may
help
elucid
mechan
sarscov
entri
develop
vaccin
immunogen
entri
inhibitor
publish
elsevi
inc
sarscov
glycoprotein
express
function
character
viral
envelop
glycoprotein
initi
entri
virus
cell
bind
cell
surfac
receptor
follow
conform
chang
lead
membran
fusion
deliveri
genom
cytoplasm
spike
glycoprotein
coronavirus
except
mediat
bind
host
cell
follow
membran
fusion
major
target
neutral
antibodi
form
characterist
corona
larg
distinct
spike
viral
envelop
complex
surfac
project
also
surround
peripheri
sarscov
particl
level
overal
sequenc
similar
predict
amino
acid
sequenc
sarscov
glycoprotein
glycoprotein
coronavirus
low
pairwis
amino
acid
ident
except
conserv
sequenc
subunit
low
level
sequenc
similar
preclud
definit
conclus
function
structur
similar
sarscov
glycoprotein
character
biochem
biophys
receptorbind
domain
rbd
local
report
clone
express
character
sarscov
fulllength
glycoprotein
variou
solubl
fragment
demonstr
fusogen
function
neutral
ph
develop
quantit
cell
fusion
report
genebas
assay
local
rbd
ntermin
residu
antibodi
plasmid
new
zealand
rabbit
immun
mg
variou
peptid
select
comput
program
immunogen
serum
immun
rabbit
test
elisa
western
blot
reactiv
sera
rabbit
immun
two
peptid
exhibit
highest
specif
activ
glycoprotein
select
studi
antibodi
denot
elicit
peptid
dvqapnytqh
tssmrgc
psskrfqpfqqfgrdc
respect
anoth
antisarscov
glycoprotein
polyclon
antibodi
recogn
amino
acid
glycoprotein
purchas
imgenex
san
diego
ca
plasmid
encod
solubl
form
kindli
provid
farzan
harvard
medic
school
boston
kind
gift
c
broder
usuh
bethesda
md
express
vector
seri
purchas
invitrogen
carlsbad
ca
construct
fulllength
glycoprotein
cdna
clone
express
vector
three
plasmid
contain
overlap
cdna
cover
fulllength
glycoprotein
code
sequenc
purchas
british
columbia
cancer
agenc
bc
canada
follow
primer
use
amplif
overlap
pcr
clone
fulllength
glycoprotein
agtcggatcc
ggtaggcttatcattagag
ccat
caggggagaa
agg
cac
gtgcctttctcccctgatgg
ga
agagcagcgccagcacc
ggtgct
ggcgctgctc
ttc
actgtctagagttcgttt
atgtgtaatg
amplifi
fulllength
gene
cut
bamhi
xbai
ligat
correspond
restrict
site
plasmid
creat
plasmid
use
gener
variou
solubl
fragment
glycoprotein
pair
primer
agtcggat
ccgaccggtgcaccacttttg
agtcgggcccct
gttcagcagcaatacc
use
amplifi
fragment
contain
residu
fragment
cut
bamhi
apai
clone
correspond
site
express
vector
invitrogen
primer
primer
ctagctcgagcaacagcatctgtg
use
amplifi
fragment
contain
residu
fragment
cut
bamhi
xhoi
clone
correspond
site
vector
fragment
gener
cut
bamhi
hincii
clone
cut
bamhi
ecorv
gener
solubl
glycoprotein
ectodomain
e
sitedirect
mutagenesi
perform
creat
apai
site
upstream
transmembran
domain
glycoprotein
gene
plasmid
digest
psti
apai
result
fragment
use
replac
pstiapai
fragment
creat
e
plasmid
pstiapai
fragment
use
replac
pstiapai
fragment
e
creat
without
tag
creat
fragment
contain
residu
follow
pair
primer
primer
gatcggatccggtacaatcacag
primer
gatcgggcccgacacactggttc
use
pcr
amplif
amplifi
fragment
digest
bamhi
apai
ligat
digest
restrict
enzym
fragment
fulllength
construct
nativ
leader
sequenc
aa
replac
mous
k
chain
leader
sequenc
protein
express
vero
cell
transfect
variou
plasmid
use
polyfect
transfect
kit
qiagen
valencia
ca
follow
manufactur
protocol
four
hour
transfect
cell
infect
recombin
vaccinia
viru
encod
gene
polymeras
solubl
fragment
obtain
cell
cultur
medium
fulllength
glycoprotein
detect
cell
lysat
immunoprecipit
purif
medium
cell
transfect
variou
solubl
fragment
collect
subject
centrifug
min
remov
cellular
debri
clear
medium
incub
either
ninta
agaros
bead
qiagen
valencia
ca
immunoprecipit
antibodi
plu
glycoprotein
gsepharos
bead
sigma
st
loui
mo
h
bead
mix
equal
volum
sd
gel
sampl
buffer
boil
min
subject
gel
analysi
fulllength
glycoprotein
cell
lyse
first
pb
supplement
mm
pmsf
h
centrifug
rpm
tabletop
eppendorf
centrifug
min
clear
lysat
either
immunoprecipit
first
use
directli
western
blot
western
blot
slot
blot
cell
express
glycoprotein
lyse
first
pbsbase
lysi
buffer
describ
debri
clear
centrifug
solubl
fragment
medium
collect
clear
describ
slot
blot
clear
lysat
medium
supernat
use
directli
blot
nitrocellulos
membran
follow
protocol
suggest
manufactur
biorad
hercul
ca
membran
subject
antibodi
detect
convent
western
blot
western
blot
monoclon
anticmyc
epitop
antibodi
invitrogen
carlsbad
ca
rabbit
polyclon
antibodi
obtain
immun
rabbit
peptid
dilut
tbst
buffer
incub
membran
h
wash
incub
secondari
antibodi
conjug
hrp
h
wash
four
time
time
min
develop
use
ecl
reagent
pierc
rockford
il
cellbind
assay
elisa
medium
contain
solubl
fragment
collect
clear
centrifug
vero
cell
incub
ml
clear
medium
contain
solubl
fragment
lg
anticmyc
epitop
antibodi
conjug
hrp
h
cell
wash
three
time
icecold
pb
collect
centrifug
cell
pellet
incub
abt
substrat
roch
indianapoli
rt
min
substrat
clear
centrifug
measur
elisa
purifi
r
minneapoli
mn
block
maxisorp
elisa
plate
ph
buffer
ng
per
well
medium
contain
variou
solubl
fragment
lg
anticmyc
epitop
antibodi
conjug
hrp
incub
well
h
well
wash
abt
substrat
ad
well
measur
min
later
fluoresc
dye
redistribut
cell
fusion
assay
hela
cell
transfect
plasmid
encod
glycoprotein
load
calcein
molecular
probe
convert
cell
calcein
green
cell
incub
medium
contain
lgml
calcein
h
co
wash
resuspend
fresh
medium
plate
target
cell
vero
stain
cmac
molecular
probe
incub
lgml
cmac
medium
min
co
cell
wash
twice
medium
incub
min
fresh
medium
wash
cover
ml
medium
well
sexpress
cell
load
calcein
ad
target
cell
incub
h
co
fusion
measur
ratio
cell
doubl
stain
total
number
target
cell
contact
glycoproteinexpress
cell
microphotograph
taken
use
methamorph
softwar
univers
imag
bgalactosidas
report
genebas
cellcel
fusion
assay
cell
plate
flask
one
day
transfect
next
day
cell
transfect
respect
use
polyfect
transfect
kit
qiagen
valencia
ca
follow
manufactur
suggest
protocol
four
hour
transfect
cell
transfect
construct
infect
polymeraseexpress
vaccinia
viru
cell
transfect
construct
infect
bgal
encod
vaccinia
viru
two
hour
infect
cell
incub
fresh
medium
transfer
overnight
incub
next
day
glycoproteinexpress
cell
cell
mix
ratio
incub
three
hour
later
cell
lyse
ad
final
concentr
cell
lysat
mix
equal
volum
cprg
substrat
measur
h
later
clone
express
purif
gener
character
fulllength
glycoprotein
solubl
fragment
character
properti
function
sarscov
protein
clone
express
vector
dna
encod
fulllength
isol
protein
residu
ectodomain
e
residu
put
transmembran
domain
cytoplasm
tail
delet
fragment
contain
ntermin
amino
acid
residu
respect
includ
put
signal
sequenc
mous
k
chain
leader
sequenc
intern
fragment
contain
residu
fig
note
stretch
amino
acid
residu
rntr
particular
case
gener
motif
krx
n
kr
x
residu
n
cleavag
precursor
convertas
thu
approxim
agreement
size
murin
coronavirus
eg
strain
jhm
residu
human
coronaviru
residu
howev
human
coronaviru
consid
consist
shorter
residu
fragment
correspond
protein
except
fulllength
glycoprotein
tag
cmyc
epitop
histidin
tag
protein
express
vero
cell
transfect
correspond
plasmid
follow
infect
vaccinia
virusexpress
polymeras
tag
protein
detect
use
anticmyc
monoclon
antibodi
fig
strike
promot
much
effici
express
glycoprotein
cmv
promot
circumst
strong
promot
fragment
solubl
concentr
cultur
supernat
invers
proport
size
fig
abl
detect
unlabel
protein
valid
data
obtain
anticmyc
antibodi
local
possibl
antigen
site
develop
rabbit
polyclon
antibodi
two
antibodi
rais
peptid
start
residu
respect
recogn
specif
tag
solubl
fragment
fig
expect
recogn
fragment
recogn
e
smaller
fragment
fig
data
shown
sensit
even
dilut
mostli
use
studi
unlik
rel
weak
fulllength
glycoprotein
express
cell
surfac
although
low
level
measur
flow
cytometri
fig
glycoprotein
fragment
fulllength
glycoprotein
ran
sdspage
gel
posit
significantli
higher
estim
molecular
weight
indic
possibl
posttransl
modif
appar
molecular
weight
kda
kda
kda
e
sabout
kda
higher
fig
band
broad
observ
low
exposur
fig
data
shown
data
indic
signific
glycosyl
observ
glycoprotein
coronavirus
base
approxim
estim
molecular
weight
appear
heavili
glycosyl
notabl
heavili
glycosyl
one
assum
glycosyl
contribut
increas
molecular
mass
sarscov
glycoprotein
cleav
although
observ
weak
band
due
smaller
protein
one
run
posit
suggest
possibl
ineffici
cleavag
fig
rule
possibl
random
digest
proteas
studi
need
determin
glycoprotein
cleavag
necessari
function
observ
measur
cytopath
effect
cell
transfect
construct
develop
data
shown
indic
possibl
fulllength
solubl
fragment
glycoprotein
may
direct
cytopath
effect
howev
higher
level
express
effect
possibl
obvious
format
syncytia
describ
next
section
could
lead
cell
death
confirm
fulllength
recombin
glycoprotein
function
find
whether
requir
fig
surfac
express
fulllength
membraneassoci
protein
demonstr
flow
cytometri
use
rabbit
polyclon
antibodi
fulllength
glycoprotein
use
transfect
cell
infect
cell
collect
incub
polyclon
antibodi
plu
antirabbit
secondari
antibodi
conjug
fitc
wash
subject
flow
cytometri
analysi
plasmid
use
express
without
gene
use
transfect
cell
control
experi
denot
neg
control
nc
fulllength
glycoprotein
denot
fig
character
e
glycoprotein
close
background
level
cleavag
e
western
blot
supernat
transfect
cell
express
e
cell
lysat
cell
express
glycoprotein
use
antibodi
shown
left
panel
show
western
blot
sampl
kept
three
day
analysi
monitor
effect
nonspecif
proteas
activ
cleavag
pattern
wherea
right
oneblot
sampl
use
immedi
prepar
viral
protein
low
ph
fusion
activ
perform
cellcel
fusion
assay
express
fulllength
glycoprotein
vector
support
fusion
express
cell
effici
evidenc
format
syncytia
variou
size
bgal
report
genebas
assay
fig
interestingli
construct
glycoprotein
leader
peptid
replac
mous
k
chain
leader
sequenc
induc
faster
format
syncytia
larger
numer
induc
encod
nativ
glycoprotein
data
shown
extent
fusion
mediat
express
use
also
higher
use
measur
report
genebas
assay
fig
data
indic
glycoprotein
may
effici
transport
cell
surfac
studi
requir
confirm
possibl
also
suggest
bgal
assay
describ
serv
quick
quantit
method
identifi
inhibitor
sarcov
entri
cell
well
tool
studi
sarscov
entri
mechan
notabl
use
assay
syncytium
format
assay
abl
detect
fusion
vero
cell
transfect
plasmid
encod
express
nativ
concentr
receptor
explor
possibl
due
low
sensit
two
assay
also
use
anoth
assay
base
fluoresc
dye
redistribut
abl
detect
fusion
singl
cell
abl
detect
statist
signific
differ
cell
transfect
plasmid
encod
fulllength
glycoprotein
variou
neg
control
includ
plasmid
encod
solubl
fragment
differ
ph
data
shown
suggest
higher
level
receptor
express
achiev
express
recombin
could
import
cellcel
fusion
underli
mechan
remain
background
measur
neg
control
subtract
fragment
result
fragment
present
percentag
c
interact
fragment
purifi
solubl
measur
elisa
experi
neg
control
nc
repres
sampl
process
exactli
way
other
except
plasmid
use
transfect
encod
protein
data
shown
repres
least
three
independ
experi
sampl
present
percentag
elucid
could
play
role
entri
cellfre
viru
cell
also
possibl
higher
level
express
could
lead
measur
cell
fusion
even
receptor
concentr
rel
low
overal
result
suggest
recombin
glycoprotein
alon
mediat
cell
fusion
fusion
occur
neutral
ph
effici
depend
concentr
receptor
molecul
attempt
local
receptorbind
domain
rbd
glycoprotein
prior
identif
sarscov
receptor
develop
assay
base
bind
variou
solubl
fragment
receptor
express
vero
cell
incub
vero
cell
suscept
sarscov
infect
sever
cell
line
solubl
fragment
result
bind
vero
cell
fragment
except
smallest
one
fig
b
data
shown
bind
proport
express
level
fragment
approxim
invers
proport
size
find
suggest
rbd
local
residu
local
rbd
use
antibodi
img
elicit
peptid
contain
residu
antibodi
inhibit
bind
fragment
vero
cell
although
bind
fragment
fig
data
shown
suggest
rbd
local
residu
rel
larg
antibodi
size
possibl
steric
hindranc
one
assum
rbd
even
downstream
residu
contrast
rbd
murin
hepat
viru
map
ntermin
amino
acid
howev
recent
rbd
local
fragment
contain
amino
acid
residu
remain
seen
whether
structur
similar
fragment
rbdcontain
fragment
sarscov
glycoprotein
eg
whether
similar
relat
use
host
replic
although
two
virus
use
differ
receptor
straightforward
cellbind
approach
describ
could
also
help
identif
viru
receptor
recent
li
et
al
report
identif
function
receptor
sarscov
receptor
identif
allow
us
valid
result
use
purifi
bind
pattern
observ
elisa
cellbind
assay
test
fragment
fig
result
also
confirm
receptor
function
systemat
studi
progress
determin
critic
residu
involv
receptor
bind
find
offer
new
tool
studi
entri
sar
viru
cell
local
rbd
also
could
help
develop
novel
vaccin
immunogen
therapeut
prevent
treatment
sar
